Compagnie Lombard Odier SCmA Sells 805 Shares of Stryker Co. (NYSE:SYK)

Compagnie Lombard Odier SCmA decreased its position in Stryker Co. (NYSE:SYK - Free Report) by 59.2% during the 1st quarter, according to its most recent filing with the SEC. The institutional investor owned 555 shares of the medical technology company's stock after selling 805 shares during the period. Compagnie Lombard Odier SCmA's holdings in Stryker were worth $207,000 as of its most recent filing with the SEC.

Several other institutional investors have also recently bought and sold shares of SYK. Kohmann Bosshard Financial Services LLC bought a new stake in Stryker during the 4th quarter worth about $25,000. Capital A Wealth Management LLC bought a new stake in Stryker during the fourth quarter worth about $26,000. Rakuten Securities Inc. raised its holdings in Stryker by 618.2% during the fourth quarter. Rakuten Securities Inc. now owns 79 shares of the medical technology company's stock worth $28,000 after acquiring an additional 68 shares in the last quarter. Centricity Wealth Management LLC bought a new stake in Stryker during the fourth quarter worth about $30,000. Finally, BankPlus Trust Department bought a new stake in shares of Stryker during the 4th quarter worth approximately $33,000. Institutional investors own 77.09% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on the company. Citigroup reiterated a "buy" rating and set a $455.00 price objective (up previously from $443.00) on shares of Stryker in a research note on Thursday, May 22nd. Truist Financial upped their price target on shares of Stryker from $390.00 to $400.00 and gave the stock a "hold" rating in a research report on Monday, May 5th. Wall Street Zen upgraded Stryker from a "hold" rating to a "buy" rating in a report on Saturday. BTIG Research set a $403.00 price target on Stryker and gave the stock a "buy" rating in a report on Monday, April 14th. Finally, Roth Mkm upped their price objective on Stryker from $405.00 to $456.00 and gave the company a "buy" rating in a research note on Friday, May 2nd. Four research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of "Moderate Buy" and a consensus price target of $427.30.

Insider Activity

In related news, Director Ronda E. Stryker sold 200,000 shares of Stryker stock in a transaction that occurred on Tuesday, May 6th. The shares were sold at an average price of $376.96, for a total transaction of $75,392,000.00. Following the sale, the director now directly owns 3,417,326 shares of the company's stock, valued at approximately $1,288,195,208.96. The trade was a 5.53% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Corporate insiders own 5.90% of the company's stock.

Stryker Price Performance

Stryker stock traded down $0.25 during mid-day trading on Monday, reaching $377.05. 965,082 shares of the company were exchanged, compared to its average volume of 1,331,423. The company has a fifty day simple moving average of $373.53 and a 200-day simple moving average of $375.55. Stryker Co. has a 12 month low of $314.93 and a 12 month high of $406.19. The company has a debt-to-equity ratio of 0.59, a current ratio of 1.95 and a quick ratio of 1.32. The firm has a market cap of $143.91 billion, a PE ratio of 48.59, a PEG ratio of 2.93 and a beta of 0.91.

Stryker (NYSE:SYK - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The medical technology company reported $2.84 EPS for the quarter, topping analysts' consensus estimates of $2.73 by $0.11. Stryker had a return on equity of 23.58% and a net margin of 13.25%. The company had revenue of $5.87 billion for the quarter, compared to analysts' expectations of $5.68 billion. During the same quarter last year, the business earned $2.50 earnings per share. Stryker's revenue was up 11.9% on a year-over-year basis. As a group, equities research analysts expect that Stryker Co. will post 13.47 earnings per share for the current fiscal year.

Stryker Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, July 31st. Investors of record on Monday, June 30th will be paid a $0.84 dividend. The ex-dividend date is Monday, June 30th. This represents a $3.36 dividend on an annualized basis and a yield of 0.89%. Stryker's dividend payout ratio (DPR) is 45.41%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.